%1

This regulatory amendment updates and clarifies a summary of Proposition 65 that must be included as an attachment to all notices of violation that are served upon violators of Proposition 65.

Proposal to amend Title 27, Cal. Code of Regulations, section 25903, Appendix A, to update and clarify the Proposition 65 summary that must be included as an attachment to all Notices of Violation that are served upon alleged violators of Proposition 65.

OEHHA has reviewed and considered comments received on the proposed rulemaking, and has decided to withdraw the proposal at this time.   

Proposal to adopt an updated No Significant Risk Level (NSRL) for polychlorinated biphenyls (PCBs) of 0.35 micrograms per day. OEHHA also proposes to adopt a Maximum Allowable Dose Level for PCBs of 2.3 ug/day.

Proposal to establish specific regulatory levels posing no significant risk for chloroethane; di(2-ethylhexyl)phthalate (DEHP); lead; lead acetate; lead phosphate; lead subacetate; methylhydrazine; methylhydrazine sulfate; 5-morpholinomethyl-3-[(5-nitrofurfurylidene)-amino]-2-oxazolidinone; MX (3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone); phenylhydrazine; phenylhydrazine hydrochloride; polygeenan; carbazole; MeIQ (2-amino-3,4-dimethylimidazo[4,5-f]quinoline); MeIQx(2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline); methyl carbamate; 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone; and trimethyl phosphate

OEHHA changes the basis for the listing of actinomycin D (CAS No. 50-76-0) as a chemical known to the state to cause cancer.  Actinomycin D was originally added to the Proposition 65 list as causing cancer via the Labor Code listing mechanism; the new basis for listing is via the formally required to be labeled or identified mechanism.

Availability of the status report on No Significant Risk Levels for carcinogens and Maximum Allowable Daily Levels for chemicals causing reproductive toxicity.

Announcement of a public meeting for consideration of chemicals as known to the state to cause cancer: 2,6-Dimethyl-N-Nitrosomorpholine and C.I. Disperse Yellow 3

C.I. Disperse Yellow 3 and 2,6-dimethyl-N-nitrosomorpholine will be considered for possible listing by the CIC at its meeting on Thursday, November 29, 2012